SEI Investments’s Fennec Pharmaceuticals FENC Stock Holding History

SEI Investments’s Portfolio FENC Stock Details FENC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$547K	Buy	+51,406	New	+$565K	﹤0.01%	2592

Other funds holding FENC

ACM

AIGH Capital Management Baltimore, Maryland $992M AUM 516.32% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Essex Investment Management Boston, Massachusetts $675M AUM 61.81% 1-Year Est. Return

CenterBook Partners Greenwich, Connecticut $2.18B AUM 12.5% 1-Year Est. Return

Los Angeles Capital Management Los Angeles, California $29.2B AUM 33.64% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Sierra Summit Advisors Incline Village, Nevada $852M AUM 73.11% 1-Year Est. Return

Legato Capital Management San Francisco, California $1.11B AUM 60.78% 1-Year Est. Return

Thompson Siegel & Walmsley Richmond, Virginia $5.37B AUM 3.99% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

SEI Investments's FENC Position: Q3 2026 in Review

SEI Investments opened a new position in Fennec Pharmaceuticals (FENC) in Q3 2026: 51,406 shares worth $547K. The stake represents ﹤0.01% of the portfolio and ranks #2592 among its holdings.

48 funds tracked by Wall St. Rank hold FENC as of Q3 2026.

SEI Investments held 51,406 shares of Fennec Pharmaceuticals worth $547K as of Q3 2026.
Fennec Pharmaceuticals was a new SEI Investments position in Q3 2026.
Fennec Pharmaceuticals made up ﹤0.01% of SEI Investments's portfolio in Q3 2026, its #2592 holding.
48 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q3 2026.

Based on SEI Investments's 13F filing for Q3 2026, filed 10 Nov 2026.